Hosted on MSN3mon
Merck’s Keytruda label expanded in the U.S. for mesotheliomaMerck (NYSE:MRK) announced Wednesday that the U.S. Food and Drug Administration (FDA) approved a label expansion for its blockbuster therapy Keytruda to allow its use as a first-line combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback